IDEAYA Biosciences: Q3 2024 Financial and Clinical Progress
PremiumCompany AnnouncementsIDEAYA Biosciences: Q3 2024 Financial and Clinical Progress
8d ago
Ideaya Biosciences reports Q3 EPS (60c), consensus (63c)
Premium
The Fly
Ideaya Biosciences reports Q3 EPS (60c), consensus (63c)
8d ago
Ideaya Biosciences announces IND clearance for Werner Helicase inhibitor
Premium
The Fly
Ideaya Biosciences announces IND clearance for Werner Helicase inhibitor
16d ago
Ideaya Biosciences management to meet with Oppenheimer
PremiumThe FlyIdeaya Biosciences management to meet with Oppenheimer
2M ago
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
Premium
The Fly
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
2M ago
Ideaya Biosciences price target lowered to $52 from $54 at Wedbush
Premium
The Fly
Ideaya Biosciences price target lowered to $52 from $54 at Wedbush
2M ago
Ideaya Biosciences announces interim darovasertib trial data
PremiumThe FlyIdeaya Biosciences announces interim darovasertib trial data
2M ago
Ideaya Biosciences announces Douglas Snyder as general counsel
Premium
The Fly
Ideaya Biosciences announces Douglas Snyder as general counsel
2M ago
Ideaya Biosciences price target raised to $68 from $63 at Stifel
Premium
The Fly
Ideaya Biosciences price target raised to $68 from $63 at Stifel
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100